2seventy bio (TSVT) Earnings Date & Reports

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TSVT is expected to report earnings to fall 54.05% to -17 cents per share on May 08

2seventy bio TSVT Stock Earnings Reports

Q1'25

Est.

$-0.17

Q4'24

Missed

by $0.17

Q3'24

Est.

$-0.19

Q2'24

Beat

by $1.21

Q1'24

Missed

by $0.26

The last earnings report on March 25 showed earnings per share of -37 cents, missing the estimate of -20 cents. With 827.45K shares outstanding, the current market capitalization sits at 258.81M.

View a ticker or compare two or three

Compare

TSVT